CAPTION CONTEST

ENTER CONTEST
Your chance to win $50!

NEWS FEEDS

SPECIAL ISSUE

ACC 2010: PAYER'S PERSPECTIVES

Health economics and cost issues from the American College of Cardiology meeting...FULL ISSUE

WEB EXCLUSIVE          ARCHIVES

GI Drugs in Late Development: DDW 2010

By Alice Goodman

SUPPLEMENTS              ARCHIVES

Highlights from the American Academy of Neurology 2010: An Update for Payers and Pharmacists on Multiple Sclerosis

Jack S. Burks, MD

Payer Perspectives on Breast Cancer: Updates from the National Comprehensive Cancer Network 15th Annual Conference

Long-Term Care: Implications of Overactive Bladder and the Latest Treatment Options for Quality Care

Eric G. Tangalos, MD, FACP, AGSF, CMD

Drug Update A Complete Resource for New Drug Approvals and Indications in 2009

A Wellness-Based Healthcare System for Chronic Diseases: Prevention, Intervention, and Innovation

WEBCAST SERIES

Impact of Market Trends on Drug Pipelines: The Need for Value-Based R&D

Mathew Sarnes, PharmD

The Role of New Healthcare Technologies in a National Wellness Strategy

Robert K. Smoldt, BS, MBA

ONLINE FIRST

Effectiveness of Anti-Tumor Necrosis Factor Agents in the Treatment of Rheumatoid Arthritis: An Observational Study

The efficacy of anti-tumor necrosis factor therapies in rheumatoid arthritis has been demonstrated in randomized clinical trials. The purpose of the present study was to evaluate the effectiveness of these agents for the treatment of rheumatoid arthritis in a real-world setting...FULL TEXT
Anna D'Souza, PhD; Brian L. Meissner, PharmD, PhD; Boxiong Tang, MD, PhD; R. Scott McKenzie, MD; Catherine T. Piech, MBA
Stakeholder Perspective by Matthew Mitchell, PharmD, MBA

COMMENTARY

The Health Reform Law: Key Changes to Be Implemented in 2010

It is impossible to overstate the extraordinary range and complexity of the newly enacted health reform law...FULL TEXT
Kip Piper, MA, FACHE

Bundled Payment: A Promising Initiative of Payment Reform

Payment reform has moved to the forefront of the conversation...FULL TEXT
Jim Evans

Correspondence: Article Supported by a Pharmaceutical Company Raises Concern

I could not help noticing that the study “Healthcare Costs Associated with Switching from Brand to Generic Levothyroxine” was funded by Abbott...FULL TEXT
Kevin Slavik, RPh, MHA

FEATURES

Prevalence of Treated Bipolar Disorders and Associated Comorbidities in Managed Care and Medicaid Populations

BPD affects more than 2.3 million adult Americans, or 1% of the population, by conservative estimates...FULL TEXT
Jeff J. Guo, PhD; Nick C. Patel, PharmD, PhD; Hong Li, PhD; Paul E. Keck Jr, MD
Stakeholder Perspective by Nirav R. Shah, MD, MPH

Impact of Etanercept Treatment on Absenteeism and Productivity

The purpose of the Work Loss and Productivity study was to quantify the impact of etanercept therapy among employees with rheumatoid arthritis...FULL TEXT
Denise Globe, PhD; Peter Mazonson, MD, MBA; Chris Santas, MBA; Regina Murphy, MBA; Annie Cheng; Xingyue Huang, BPharm, PhD; Arthur Kavanaugh, MD
Stakeholder Perspective by Atheer A. Kaddis, PharmD

Health Benefit Coverage, Reimbursement, and Impacts on Traditional Pharmaceutical Channels

Pharmaceutical manufacturers face an increasing drug utilization dilemma...FULL TEXT
F. Randy Vogenberg, RPh, PhD
Stakeholder Perspective by Gary M. Owens, MD

GENERIC DRUG TRENDS

Impact of 2 Copay Waivers in a Generic Incentive Program

Strategies such as these result in a reduction of overall pharmacy costs and a change in plan member behavior...FULL TEXT Anthony F. Liu, MSCS; Tom Jecklin; Geoffrey Lee; James Hogan

MEETING HIGHLIGHTS

AMCP

Medication Adherence: Effectiveness of Physician Alerts to Resolve Potential Gaps in Pharmacotherapy

Costs resulting from nonadherence have been estimated to exceed a staggering $100 billion annually...FULL TEXT
Joshua N. Liberman, PhD; Janice Moore, MPH; Asif Ally, RPh, MBA; Troyen A. Brennan, JD, MD

Patient Out-of-Pocket Cost Affects Adherence to Oral Oncology Medications
Cost-Effectiveness Trends for 20 Top-Selling Drugs
Effect of Diabetes Medication Adherence on Costs and Outcomes
Applying Pharmacogenomics in Oncology Care

DDW

New Approaches to Treating HCV Infection

American Society of Hypertension

Long-Term VA Study Raises the Bar for BP Control
New ARB Outperforms Older Agents
Phase 4 Study Targets Hispanics with Hypertension

DRUG PIPELINE

Promising New Approaches to Multiple Sclerosis Medications: AAN 2010

e-Newsletter

E-mail address